Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Roya Khosravi-Far"'
Autor:
Ferry Sandra, Roya Khosravi-Far
Publikováno v:
Indonesian Biomedical Journal, Vol 6, Iss 3, Pp 157-62 (2014)
BACKGROUND: Our previous report showed that phosphorylated-survivin at Ser81 induces survivin back loop to activate protein kinase A (PKA) in the cytoprotection mechanism. Activated PKA could possibly induce the cytoprotection via Phosphatydilinosito
Externí odkaz:
https://doaj.org/article/ee83e495607c4aefa752d3d9b4ece0ea
Autor:
Ferry Sandra, Roya Khosravi-Far
Publikováno v:
Indonesian Biomedical Journal, Vol 3, Iss 2, Pp 138-42 (2011)
BACKGROUND: Survivin, a bifunctional protein, acts as suppressor of apoptosis and has an essential role in mitosis. Survivin is physically phosphorylated on Thr34, and other important sites such as Thr117, Ser20, Thr48 and Ser81. Our previous report
Externí odkaz:
https://doaj.org/article/ebc4bf150bbe49e9bb9beb60864fa779
Autor:
Ferry Sandra, Roya Khosravi-Far
Publikováno v:
Indonesian Biomedical Journal, Vol 2, Iss 3, Pp 113-7 (2010)
BACKGROUND: Survivin is rarely expressed in normal healthy adult tissues, however, it is upregulated in the majority of cancers. Survivin, which belongs to IAPs family, has been widely reported to protect cells from apoptosis by inhibiting caspases p
Externí odkaz:
https://doaj.org/article/1d784415a2a74c8fb121ef7c184b3fb1
Autor:
Octavian Bucur, Andreea Lucia Stancu, Ioana Goganau, Stefana Maria Petrescu, Bodvael Pennarun, Thierry Bertomeu, Rajan Dewar, Roya Khosravi-Far
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e77390 (2013)
Emergence of resistance to Tyrosine-Kinase Inhibitors (TKIs), such as imatinib, dasatinib and nilotinib, in Chronic Myelogenous Leukemia (CML) demands new therapeutic strategies. We and others have previously established bortezomib, a selective prote
Externí odkaz:
https://doaj.org/article/9b01a2611d5a4c6c886b3dc6d9130a42
Autor:
Ling Wang, Shamit K Dutta, Tatsuyoshi Kojima, Xiaolei Xu, Roya Khosravi-Far, Stephen C Ekker, Debabrata Mukhopadhyay
Publikováno v:
PLoS ONE, Vol 2, Iss 11, p e1161 (2007)
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF), one of the crucial pro-angiogenic factors, functions as a potent inhibitor of endothelial cell (EC) apoptosis. Previous progress has been made towards delineating the VPF/VEG
Externí odkaz:
https://doaj.org/article/ffcc8f091c634c219453c11f70f0f10a
Autor:
Jianqiao Cui, Xun Gong, Soo-Yeon Cho, Xiaojia Jin, Sungyun Yang, Roya Khosravi-Far, Michael S. Strano
Publikováno v:
The Journal of Physical Chemistry C. 127:606-620
Autor:
Roya Khosravi-Far, Kenneth Miller, Heather Yeckes Rodin, Ruibao Ren, Catherine Wu, Saghi Ghaffari, Alexandra Grassian, Tanya Santos, Armelle Melet, M. Rajan Dewar, Jeffery L. Kutok, Keli Song, Zainab Jagani
Supplementary Figure 3 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b318b70177cdacca65b26455ee2cfd
https://doi.org/10.1158/0008-5472.22378436.v1
https://doi.org/10.1158/0008-5472.22378436.v1
Autor:
Roya Khosravi-Far, Kenneth Miller, Heather Yeckes Rodin, Ruibao Ren, Catherine Wu, Saghi Ghaffari, Alexandra Grassian, Tanya Santos, Armelle Melet, M. Rajan Dewar, Jeffery L. Kutok, Keli Song, Zainab Jagani
Supplementary Figure 10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::474243a1478e28f7eebaba464439e228
https://doi.org/10.1158/0008-5472.22378442
https://doi.org/10.1158/0008-5472.22378442
Autor:
Roya Khosravi-Far, Jack Lawler, Nordine Benhaga, Xuefeng Zhang, Mark Duquette, Robin Humphreys, Min Ye, Taiguang Jin, Sareh Parangi, Keli Song, Bin Ren
As tumor development relies on a coordination of angiogenesis and tumor growth, an efficient antitumor strategy should target both the tumor and its associated vessels. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfd9bbe3b898ca18ed4de04457334ae9
https://doi.org/10.1158/0008-5472.c.6499284.v1
https://doi.org/10.1158/0008-5472.c.6499284.v1
Supplementary Figure 1 Legend from Transduction of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand into Hematopoietic Cells Leads to Inhibition of Syngeneic Tumor Growth In vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ff1ed0577d77e829ee59a3e0f3f000
https://doi.org/10.1158/0008-5472.22364835.v1
https://doi.org/10.1158/0008-5472.22364835.v1